Cytomx Therapeutics Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$2.95

-0.01 (-0.34%)

As of Jun 21, 10:13 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 14 93%

Hold 1 7%

Sell 0 0%

Price Target

Analyst Price Target +2,036.9% upside

Low Target $39.26

Average Target $63.04

High Target $88.15

Current Price $2.95

Current
$2.95

Target
$63.04

$39.26 $63.04 avg $88.15

Scenario Analysis

Bear Case

$39.26

1,230.8%

Low target

Base Case

$63.04

+2,036.9%

Avg target

Bull Case

$88.15

+2,888.1%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$8.21

-64.1% from high

52-Week Low

$1.72

+71.5% from low

Target vs 52W High

$63.04

+667.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.0%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+190.0%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-6.4%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.6%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-64.5%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.7%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-39.1%